Related Experiment Video
Updated: Jul 1, 2025

04:28
Lung Tumor Cell Recruitment Assay
Published on: February 26, 2019
5.3K
Platelets induce CD39 expression in tumor cells to facilitate tumor metastasis
Zhaochen Ning1, Keyan Liu2, Hui Zhang1
1Jining Key Laboratory of Immunology, Jining Medical University, Jining, 272067, China.
British Journal of Cancer
|March 9, 2024
Summary
Platelets induce CD39 expression in tumor cells through direct contact, promoting immune suppression and cancer metastasis. This finding highlights CD39 as a potential therapeutic target for reducing tumor spread.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Metastasis involves tumor cell evolution influenced by the microenvironment.
- Platelets interact with tumor cells, aiding hematogenous metastasis and tumor development.
- Molecular mechanisms of platelet-tumor cell interactions in metastasis remain unclear.
Purpose of the Study:
- Investigate the role of platelets in regulating tumor cell gene expression during metastasis.
- Determine the impact of platelet-induced CD39 expression on tumor cell behavior, immunity, and metastasis.
- Elucidate the molecular mechanisms by which platelets promote tumor metastasis.
Main Methods:
- RNA-sequencing to identify platelet-mediated gene expression changes in tumor cells.
- Experimental metastasis models using wild-type, NCG, and CD39 knockout mice.
- Assessment of CD39 expression, tumor cell invasion, proliferation, migration, and anti-tumor immunity.
Main Results:
- Platelets significantly up-regulate CD39 expression in tumor cells via direct contact.
- Tumor cell-expressed CD39 promotes invasion and metastasis but not proliferation or migration.
- CD39 silencing reduces metastasis, while its overexpression enhances it and inhibits anti-tumor immunity.
- Findings were validated in CD39 knockout mice and human samples.
Conclusions:
- Direct platelet-tumor cell contact induces CD39 expression in cancer cells.
- Induced CD39 contributes to immune suppression and enhances tumor cell metastasis.
- CD39 represents a novel target for anti-metastasis therapies.
Related Concept Videos
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K

